Literature DB >> 19909911

Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms.

Maria C Rodriguez-Oroz1, Marjan Jahanshahi, Paul Krack, Irene Litvan, Raúl Macias, Erwan Bezard, José A Obeso.   

Abstract

A dopaminergic deficiency in patients with Parkinson's disease (PD) causes abnormalities of movement, behaviour, learning, and emotions. The main motor features (ie, tremor, rigidity, and akinesia) are associated with a deficiency of dopamine in the posterior putamen and the motor circuit. Hypokinesia and bradykinesia might have a dual anatomo-functional basis: hypokinesia mediated by brainstem mechanisms and bradykinesia by cortical mechanisms. The classic pathophysiological model for PD (ie, hyperactivity in the globus pallidus pars interna and substantia nigra pars reticulata) does not explain rigidity and tremor, which might be caused by changes in primary motor cortex activity. Executive functions (ie, planning and problem solving) are also impaired in early PD, but are usually not clinically noticed. These impairments are associated with dopamine deficiency in the caudate nucleus and with dysfunction of the associative and other non-motor circuits. Apathy, anxiety, and depression are the main psychiatric manifestations in untreated PD, which might be caused by ventral striatum dopaminergic deficit and depletion of serotonin and norepinephrine. In this Review we discuss the motor, cognitive, and psychiatric manifestations associated with the dopaminergic deficiency in the early phase of the parkinsonian state and the different circuits implicated, and we propose distinct mechanisms to explain the wide clinical range of PD symptoms at the time of diagnosis.

Entities:  

Mesh:

Year:  2009        PMID: 19909911     DOI: 10.1016/S1474-4422(09)70293-5

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  216 in total

1.  Cerebral cortical areas in which thickness correlates with severity of motor deficits of Parkinson's disease.

Authors:  Chul Hyoung Lyoo; Young Hoon Ryu; Myung Sik Lee
Journal:  J Neurol       Date:  2011-04-22       Impact factor: 4.849

2.  Sentence processing in Lewy body spectrum disorder: the role of working memory.

Authors:  Rachel G Gross; Corey T McMillan; Keerthi Chandrasekaran; Michael Dreyfuss; Sharon Ash; Brian Avants; Philip Cook; Peachie Moore; David J Libon; Andrew Siderowf; Murray Grossman
Journal:  Brain Cogn       Date:  2012-01-02       Impact factor: 2.310

3.  Difficulty processing temporary syntactic ambiguities in Lewy body spectrum disorder.

Authors:  Murray Grossman; Rachel G Gross; Peachie Moore; Michael Dreyfuss; Corey T McMillan; Philip A Cook; Sherry Ash; Andrew Siderowf
Journal:  Brain Lang       Date:  2011-09-29       Impact factor: 2.381

4.  Parkinson disease: Depression and anxiety in Parkinson disease.

Authors:  Pablo Martínez-Martín; Javier Damián
Journal:  Nat Rev Neurol       Date:  2010-05       Impact factor: 42.937

5.  Computer-Based Visualization System for the Study of Deep Brain Structures Involved in Parkinson's Disease.

Authors:  Juan A Juanes; Pablo Ruisoto; José A Obeso; Alberto Prats; Joan San-Molina
Journal:  J Med Syst       Date:  2015-09-14       Impact factor: 4.460

Review 6.  Behavioral and Genetic Evidence for GIRK Channels in the CNS: Role in Physiology, Pathophysiology, and Drug Addiction.

Authors:  Jody Mayfield; Yuri A Blednov; R Adron Harris
Journal:  Int Rev Neurobiol       Date:  2015-06-22       Impact factor: 3.230

Review 7.  A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition.

Authors:  Marjan Jahanshahi; Ignacio Obeso; John C Rothwell; José A Obeso
Journal:  Nat Rev Neurosci       Date:  2015-11-04       Impact factor: 34.870

8.  Neuroprotective Activities of Spirulina platensis in the 6-OHDA Model of Parkinson's Disease Are Related to Its Anti-Inflammatory Effects.

Authors:  Francisco Arnaldo Viana Lima; Ivan Pinheiro Joventino; Francisca Pinheiro Joventino; Aline Cordeiro de Almeida; Kelly Rose Tavares Neves; Marta Regina do Carmo; Luzia Kalyne Almeida Moreira Leal; Geanne Matos de Andrade; Glauce Socorro de Barros Viana
Journal:  Neurochem Res       Date:  2017-08-31       Impact factor: 3.996

Review 9.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

Review 10.  Parkinson's disease.

Authors:  Timothy R Mhyre; James T Boyd; Robert W Hamill; Kathleen A Maguire-Zeiss
Journal:  Subcell Biochem       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.